Primary peritoneal carcinoma Trials in Detroit, United States
Conditions / Primary peritoneal carcinoma / Detroit, United States
Primary peritoneal carcinoma has been the subject of sustained clinical investigation across multiple research sites.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01139957 | Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer | COMPLETED | — |
| NCT05579366 | Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) | RECRUITING | PHASE1/PHASE2 |
| NCT02315469 | Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery | COMPLETED | — |
| NCT03849469 | A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors | COMPLETED | PHASE1 |
| NCT05527184 | First in Human Study of IMGN151 in Recurrent Gynaecological Cancers | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT05274451 | A Study to Investigate LYL797 in Adults With Solid Tumors | TERMINATED | PHASE1 |
| NCT02631876 | A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer | COMPLETED | PHASE3 |
| NCT00958698 | Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | UNKNOWN | NA |
| NCT05198804 | A Study of ZN-c3 and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT03602079 | Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene | COMPLETED | PHASE1/PHASE2 |